Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 27, 2022

SELL
$42.05 - $47.77 $11,816 - $13,423
-281 Reduced 1.46%
19,007 $827,000
Q1 2022

Apr 25, 2022

SELL
$40.23 - $47.74 $31,862 - $37,810
-792 Reduced 3.94%
19,288 $840,000
Q4 2021

Feb 10, 2022

SELL
$38.88 - $45.31 $103,070 - $120,116
-2,651 Reduced 11.66%
20,080 $886,000
Q3 2021

Nov 15, 2021

BUY
$38.79 - $43.16 $157,991 - $175,790
4,073 Added 21.83%
22,731 $869,000
Q2 2021

Aug 13, 2021

BUY
$36.52 - $41.46 $76,618 - $86,983
2,098 Added 12.67%
18,658 $743,000
Q1 2021

May 13, 2021

BUY
$34.27 - $40.01 $67,923 - $79,299
1,982 Added 13.6%
16,560 $591,000
Q4 2020

Feb 03, 2021

BUY
$34.07 - $39.94 $64,358 - $75,446
1,889 Added 14.89%
14,578 $536,000
Q3 2020

Nov 10, 2020

BUY
$38.11 - $42.99 $42,568 - $48,019
1,117 Added 9.65%
12,689 $478,000
Q2 2020

Aug 12, 2020

BUY
$37.87 - $43.58 $41,959 - $48,286
1,108 Added 10.59%
11,572 $472,000
Q1 2020

Apr 16, 2020

BUY
$32.47 - $48.83 $57,666 - $86,722
1,776 Added 20.44%
10,464 $396,000
Q4 2019

Jan 31, 2020

BUY
$42.0 - $48.25 $15,246 - $17,514
363 Added 4.36%
8,688 $408,000
Q3 2019

Oct 18, 2019

BUY
$40.46 - $43.52 $16,467 - $17,712
407 Added 5.14%
8,325 $355,000
Q2 2019

Jul 26, 2019

BUY
$39.4 - $42.7 $65,088 - $70,540
1,652 Added 26.36%
7,918 $317,000
Q1 2019

Apr 24, 2019

BUY
$38.57 - $42.69 $9,295 - $10,288
241 Added 4.0%
6,266 $262,000
Q4 2018

Feb 05, 2019

BUY
$37.8 - $42.69 $8,807 - $9,946
233 Added 4.02%
6,025 $230,000
Q3 2018

Nov 13, 2018

BUY
$39.75 - $42.69 $5,962 - $6,403
150 Added 2.66%
5,792 $233,000
Q2 2018

Aug 08, 2018

SELL
$39.61 - $42.76 $21.8 Million - $23.6 Million
-550,845 Reduced 98.99%
5,642 $227,000
Q3 2017

Oct 11, 2017

BUY
$39.44 - $41.55 $19,207 - $20,234
487 Added 0.09%
556,487 $11.1 Million
Q2 2017

Aug 11, 2017

BUY
N/A
556,000
556,000 $0

Others Institutions Holding GSK

About GSK PLC


  • Ticker GSK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,033,689,984
  • Market Cap $69.2B
  • Description
  • GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...
More about GSK
Track This Portfolio

Track Bailard, Inc. Portfolio

Follow Bailard, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bailard, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Bailard, Inc. with notifications on news.